Last data update: May 13, 2024. (Total: 46773 publications since 2009)
Records 1-2 (of 2 Records) |
Query Trace: Mulvihill L[original query] |
---|
Prevalence and functioning of children with cerebral palsy in four areas of the United States in 2006: a report from the Autism and Developmental Disabilities Monitoring Network
Kirby RS , Wingate MS , Van Naarden Braun K , Doernberg NS , Arneson CL , Benedict RE , Mulvihill B , Durkin MS , Fitzgerald RT , Maenner MJ , Patz JA , Yeargin-Allsopp M . Res Dev Disabil 2011 32 (2) 462-9 AIM: To estimate the prevalence of cerebral palsy (CP) and the frequency of co-occurring developmental disabilities (DDs), gross motor function (GMF), and walking ability using the largest surveillance DD database in the US. METHODS: We conducted population-based surveillance of 8-year-old children in 2006 (N=142,338), in areas of Alabama, Georgia, Wisconsin, and Missouri. This multi-site collaboration involved retrospective record review at multiple sources. We reported CP subtype, co-occurring DDs, Gross Motor Function Classification System (GMFCS) level, and walking ability as well as CP period prevalence by race/ethnicity and sex. RESULTS: CP prevalence was 3.3 (95% confidence interval [CI]: 3.1-3.7) per 1000 and varied by site, ranging from 2.9 (Wisconsin) to 3.8 (Georgia) per 1000, 8-year olds (p<0.02). Approximately 81% had spastic CP. Among children with CP, 8% had an autism spectrum disorder and 35% had epilepsy. Using the GMFCS, 38.1% functioned at the highest level (I), with 17.1% at the lowest level (V). Fifty-six percent were able to walk independently and 33% had limited or no walking ability. INTERPRETATION: Surveillance data are enhanced when factors such as functioning and co-occurring conditions known to affect clinical service needs, quality of life, and health care are also considered. |
A multidisciplinary investigation of a polycythemia vera cancer cluster of unknown origin
Seaman V , Dearwent SM , Gable D , Lewis B , Metcalf S , Orloff K , Tierney B , Zhu J , Logue J , Marchetto D , Ostroff S , Hoffman R , Xu M , Carey D , Erlich P , Gerhard G , Roda P , Iannuzzo J , Lewis R , Mellow J , Mulvihill L , Myles Z , Wu M , Frank A , Gross-Davis CA , Klotz J , Lynch A , Weissfeld J , Weinberg R , Cole H . Int J Environ Res Public Health 2010 7 (3) 1139-1153 Cancer cluster investigations rarely receive significant public health resource allocations due to numerous inherent challenges and the limited success of past efforts. In 2008, a cluster of polycythemia vera, a rare blood cancer with unknown etiology, was identified in northeast Pennsylvania. A multidisciplinary group of federal and state agencies, academic institutions, and local healthcare providers subsequently developed a multifaceted research portfolio designed to better understand the cause of the cluster. This research agenda represents a unique and important opportunity to demonstrate that cancer cluster investigations can produce desirable public health and scientific outcomes when necessary resources are available. copyright 2010 by the authors. |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 13, 2024
- Content source:
- Powered by CDC PHGKB Infrastructure